Clock has startedIf Promis can show any efficacy in their 6 month interim results then the tranche A warrants will be exercised at 2.15 a share, if not then it's disaster for us all. Now, if they show no brain edema at the end of February, then that's a big step forward to completing a JV. Don't forget dosing is monthly and scans are more frequent. This is a lottery play and if they can stop AD and show efficacy , then the stock will go up like one of Elon Musks rockets. Here's dreaming.